West Pharmaceutical Services (WST)
Cost of Revenue
$2.10B
TTM · Period ending: · USD
WST Cost of Revenue
Latest reported$2.10Bperiod ending
Latest reported$2.10Bperiod ending
WST TTM Cost of Revenue ($0.00 → $2.10B)
TTM cost of revenue
High-resolution chart · PNG
WST cost of revenue history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Cost of Revenue (USD) |
|---|---|
| 296,800,000 | |
| 295,700,000 | |
| 289,700,000 | |
| 287,800,000 | |
| 288,700,000 | |
| 288,800,000 | |
| 289,100,000 | |
| 292,000,000 | |
| 291,700,000 | |
| 288,100,000 | |
| 282,200,000 | |
| 279,100,000 | |
| 274,600,000 | |
| 280,400,000 | |
| 288,500,000 | |
| 295,400,000 | |
| 301,100,000 | |
| 301,400,000 | |
| 302,000,000 | |
| 300,300,000 | |
| 295,000,000 | |
| 285,000,000 | |
| 265,500,000 | |
| 260,600,000 | |
| 246,200,000 | |
| 230,800,000 | |
| 225,900,000 | |
| 223,200,000 | |
| 219,000,000 | |
| 217,500,000 | |
| 222,100,000 | |
| 221,400,000 | |
| 222,700,000 | |
| 223,500,000 | |
| 218,100,000 | |
| 215,400,000 | |
| 216,100,000 | |
| 215,500,000 | |
| 221,400,000 | |
| 221,100,000 | |
| 220,700,000 | |
| 223,200,000 | |
| 221,200,000 | |
| 183,600,000 | |
| 124,200,000 | |
| 61,300,000 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 |